These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6219835)

  • 1. Maternal cell-mediated immunity in normal and pre-eclamptic pregnancy.
    Sargent IL; Redman CW; Stirrat GM
    Clin Exp Immunol; 1982 Dec; 50(3):601-9. PubMed ID: 6219835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal cell-mediated immunity in pregnancy--lymphocyte responses of mothers and their non-pregnant HLA identical sisters to paternal HLA.
    Moore MP; Sargent IL; Ting A; Redman CW
    Clin Exp Immunol; 1983 Oct; 54(1):91-4. PubMed ID: 6225586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leucocyte antigens and mixed lymphocyte reaction in severe pre-eclampsia.
    Jenkins DM; Need JA; Scott JS; Morris H; Pepper M
    Br Med J; 1978 Mar; 1(6112):542-4. PubMed ID: 147119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal-fetal mixed lymphocyte reactivity in pre-eclampsia.
    Curzen P; Jones E; Gaugas JM
    Br J Exp Pathol; 1977 Oct; 58(5):500-3. PubMed ID: 145232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-eclampsia--a state of mother-fetus immune imbalance.
    Birkeland SA; Kristofferson K
    Lancet; 1979 Oct; 2(8145):720-3. PubMed ID: 90806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mixed culture of maternal and neonatal lymphocytes normally and in late pregnancy toxicosis].
    Lozovskaia LS; Fedorova OE; Sinitsyna MA; Kipnis SL
    Akush Ginekol (Mosk); 1979 Sep; (9):17-9. PubMed ID: 158990
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological phenomena in pre-eclamptic toxaemia.
    Need JA
    Clin Obstet Gynaecol; 1979 Dec; 6(3):443-60. PubMed ID: 389523
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppressed mixed lymphocyte reaction in couples with intrauterine growth retardation pregnancies.
    Tsushima R; Fujii T; Nakamura A; Okai T; Juji T; Taketani Y
    Int J Gynaecol Obstet; 1995 Jan; 48(1):37-42. PubMed ID: 7698381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T lymphocyte subpopulations and lymphocyte proliferative activity in normal and pre-eclamptic pregnancy.
    Malinowski A; Szpakowski M; Tchórzewski H; Zeman K; Pawlowicz P; Wozniak P
    Eur J Obstet Gynecol Reprod Biol; 1994 Jan; 53(1):27-31. PubMed ID: 7910568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immunity in normal pregnancy and pre-eclampsia.
    Alanen A; Lassila O
    J Reprod Immunol; 1982 Dec; 4(6):349-54. PubMed ID: 7153978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcome in human couples with recurrent spontaneous abortions: HLA antigen profiles; HLA antigen sharing; female serum MLR blocking factors; and paternal leukocyte immunization.
    Beer AE; Semprini AE; Zhu XY; Quebbeman JF
    Exp Clin Immunogenet; 1985; 2(3):137-53. PubMed ID: 2978830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal cell-mediated sensitisation to paternal HLA may occur, but is not a regular event in normal human pregnancy.
    Sargent IL; Arenas J; Redman CW
    J Reprod Immunol; 1987 Feb; 10(2):111-20. PubMed ID: 2955114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal immune system during human gestation.
    Gall SA
    Semin Perinatol; 1977 Apr; 1(2):119-33. PubMed ID: 224506
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunology of pregnancy. II. Control and pathology of the maternal immune response (author's transl)].
    Soubiran P; Revillard JP
    Pathol Biol (Paris); 1977 Nov; 25(9):659-71. PubMed ID: 23513
    [No Abstract]   [Full Text] [Related]  

  • 15. How Does the maternal immune system contribute to the development of pre-eclampsia?
    Moffett A; Hiby SE
    Placenta; 2007 Apr; 28 Suppl A():S51-6. PubMed ID: 17292469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular hyperreactivity to placenta in toxemia of pregnancy.
    Toder V; Eichenbrenner I; Amit S; Serr D; Nebel L
    Eur J Obstet Gynecol Reprod Biol; 1979 Dec; 9(6):379-84. PubMed ID: 400869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inadequate tolerance induction may induce pre-eclampsia.
    Saito S; Sakai M; Sasaki Y; Nakashima A; Shiozaki A
    J Reprod Immunol; 2007 Dec; 76(1-2):30-9. PubMed ID: 17935792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paternal contribution of HLA-G*0106 significantly increases risk for pre-eclampsia in multigravid pregnancies.
    Tan CY; Ho JF; Chong YS; Loganath A; Chan YH; Ravichandran J; Lee CG; Chong SS
    Mol Hum Reprod; 2008 May; 14(5):317-24. PubMed ID: 18353802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of maternal responsiveness to paternal antigen by maternal plasma.
    Pence H; Petty WM; Rocklin RE
    J Immunol; 1975 Jan; 114(1 Pt 2):525-8. PubMed ID: 123259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads.
    Hylenius S; Andersen AM; Melbye M; Hviid TV
    Mol Hum Reprod; 2004 Apr; 10(4):237-46. PubMed ID: 14985477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.